Bliss GVS Pharma Ltd
Healthcare | Small Cap
Bliss GVS Pharma Ltd presents a strong yet mixed financial profile. The company's greatest strengths are its exceptional financial health and growth. It demonstrates outstanding profitability, minimal debt, and a very strong ability to cover its financial obligations, indicating a low-risk profile. Growth has been explosive across revenue, profits, and earnings, suggesting strong market demand and successful expansion strategies. However, a significant area of weakness is operational efficiency. The company is slow in converting its assets into sales and collecting payments from customers, which can tie up cash. The financial strategy appears focused on aggressive reinvestment for growth, evidenced by high capital spending and low dividend payouts. The future outlook is positive due to strong growth and profitability, but contingent on translating these strengths into improved operational efficiency over time.
Latest Report
View AllThe Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.
Latest News
View AllThe Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.
- Valuation MetricsNeutral
- Market Metrics
- Stock Reports
- Stock News
- Growth Ratio10.00
- Financial Ratio5.40
- Profitability Ratio10.00
- Efficiency Ratio3.00
- Coverage Ratio10.00
- Solvency Ratio10.00
- Liquidity Ratio8.38
- Peer Assessment
- Management AssessmentWeak
- Risk AssessmentWeak
- 1 HourBullish
- 2 HoursBullish
- 4 HoursBullish
- 1 DayBullish
- 1 WeekBullish
- 1 MonthBullish
Bliss GVS Pharma Ltd presents a strong yet mixed financial profile. The company's greatest strengths are its exceptional financial health and growth. It demonstrates outstanding profitability, minimal debt, and a very strong ability to cover its financial obligations, indicating a low-risk profile. Growth has been explosive across revenue, profits, and earnings, suggesting strong market demand and successful expansion strategies. However, a significant area of weakness is operational efficiency. The company is slow in converting its assets into sales and collecting payments from customers, which can tie up cash. The financial strategy appears focused on aggressive reinvestment for growth, evidenced by high capital spending and low dividend payouts. The future outlook is positive due to strong growth and profitability, but contingent on translating these strengths into improved operational efficiency over time.
Overall Valuation Score
P/E RATIO (TTM)
21.50
Industry Median
36.13
Small Cap Median
35.79
P/E RATIO
27.92
P/B RATIO
2.09
Industry Median
6.08
Small Cap Median
6.08
P/S RATIO
N/A
Industry Median
5.75
Small Cap Median
5.17
Others
PEG RATIO
-6.16
EV/EBITDA RATIO
14.53
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹223.36 as on Jun 2, 2026.
Unlock Live Chart
Please login to view interactive real-time technical charts powered by TradingView.
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
0.00
Today's Low
0.00
Today's High
The company has demonstrated exceptional performance in growth across all key areas. It has achieved outstanding increases in revenue, operating profit, and net income, indicating strong market demand and effective business expansion strategies. This rapid expansion is also reflected in the significant growth of its assets and earnings per share. This powerful and broad-based growth is a very positive indicator for the company's future prospects and its strengthening position in the market.
| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 29.46 | 0.67 | 2.39 | 5.19 | 14.44 |
| Operating Profit Growth Rate | 10.28 | -0.85 | 29.06 | -15.89 | 29.13 |
| Earnings Per Share (EPS) Growth | -78.16 | 368.97 | 6.03 | 10.96 | 52.63 |
| Asset Growth Rate | 2.97 | 4.33 | 4.75 | 7.34 | 14.68 |
| Net Income Growth Rate | -68.92 | 234.78 | 6.49 | 9.76 | 50 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
The company presents a mixed financial picture from a direct shareholder return perspective. On the positive side, the underlying net asset value per share (book value) is excellent, and earnings per share are good. However, the cash return to shareholders in the form of dividends is low. Furthermore, the company engages in high capital expenditure, which, while potentially fueling future growth, represents a significant cash outlay and limits funds available for other uses, including higher dividends.
| Financial Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Adjusted Earnings Per Share (Adjusted EPS) | 5.1 | 8.3 | 10.8 | 8.73 | 13 |
| Cash Earnings Per Share (Cash EPS) | 4 | 9.6 | 10.8 | 10.82 | 15.27 |
| Book Value Per Share | 81.8 | 88.3 | 96.7 | 95.55 | 108.45 |
| Dividend Per Share (DPS) | 0.49 | 0.48 | 0.5 | 0.48 | 0.98 |
| Capital Expenditures (CapEx) | 73 | 93 | 27 | 73 | 53 |
Adjusted Earnings Per Share (Adjusted EPS)
Cash Earnings Per Share (Cash EPS)
Book Value Per Share
Dividend Per Share (DPS)
Capital Expenditures (CapEx)
The company's profitability is outstanding across all measures. From the initial profit on goods sold to the final net profit after all expenses, the company demonstrates excellent performance. It is highly effective at managing its costs and maintaining pricing power to maximize returns. The high returns on equity, assets, and capital employed confirm that the company is not just growing, but doing so in a highly profitable manner, creating significant value for its stakeholders.
| Profitability Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Gross Profit Margin | 13.52 | 13.03 | 16.23 | 12.1 | 14.13 |
| Return on Capital Employed (ROCE) | 14 | 12 | 14 | 12 | 17 |
| Return on Equity (ROE) | 2.81 | 8.72 | 8.48 | 8.56 | 11.32 |
| Return on Assets (ROA) | 10.64 | 10.11 | 12.46 | 9.76 | 10.99 |
| Operating Margin | 15.8 | 15.56 | 19.61 | 15.68 | 17.69 |
| Net Margin | 3.08 | 10.24 | 10.65 | 11.11 | 14.56 |
Gross Profit Margin
Return on Capital Employed (ROCE)
Return on Equity (ROE)
Return on Assets (ROA)
Operating Margin
Net Margin
This is the company's most significant area of weakness. The analysis reveals that the company is not very effective at using its assets to generate sales. It takes a considerable amount of time to sell its inventory and an even longer time to collect payments from its customers. This operational sluggishness ties up a large amount of cash in working capital. While the company is growing and profitable, its underlying operational processes appear inefficient, which could limit its ability to maximize returns on its investments.
| Efficiency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Fixed Asset Turnover Ratio | 2.66 | 1.98 | 2.08 | 2 | 2.02 |
| Inventory Turnover Ratio | 5.79 | 5.75 | 5.85 | 5.84 | 5.75 |
| Receivables Turnover Ratio | 1.74 | 1.93 | 1.95 | 1.92 | 1.94 |
| Days Sales in Inventory Ratio | 63.04 | 63.48 | 62.39 | 62.5 | 63.48 |
| Receivable Days | 209.77 | 189.12 | 187.18 | 190.1 | 188.14 |
| Capital Turnover Ratio | 0.88 | 0.81 | 0.76 | 0.74 | 0.76 |
Fixed Asset Turnover Ratio
Inventory Turnover Ratio
Receivables Turnover Ratio
Days Sales in Inventory Ratio
Receivable Days
Capital Turnover Ratio
The company's ability to cover its financial commitments is excellent. Its earnings are many times greater than what is needed to handle interest payments on its minimal debt. There is also a very healthy cushion for paying dividends to shareholders. This high level of coverage provides a significant safety margin, reinforcing the company's low-risk financial profile and demonstrating its strong earnings power relative to its obligations.
| Coverage Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Interest Coverage Ratio | 11.8 | 11.6 | 17.71 | 16.75 | 16.83 |
| Equity Dividend Coverage Ratio | 2.94 | 14.29 | 14.29 | 16.67 | 12.5 |
Interest Coverage Ratio
Equity Dividend Coverage Ratio
The company's long-term financial stability is exceptional. It operates with a very low level of debt, meaning its assets are predominantly financed by the owners' equity rather than borrowed money. This conservative financial structure significantly reduces the risk associated with interest payments and financial distress, particularly during economic downturns. This provides a very strong foundation for sustainable operations and future growth, making it very secure from a long-term risk perspective.
| Solvency Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debt Ratio | 0.03 | 0.05 | 0.05 | 0.03 | 0.02 |
| Debt to Equity Ratio | 0.03 | 0.05 | 0.05 | 0.03 | 0.02 |
| Equity Ratio | 0.97 | 0.95 | 0.95 | 0.97 | 0.98 |
| Debt To Asset Ratio | 0.02 | 0.04 | 0.04 | 0.03 | 0.01 |
Debt Ratio
Debt to Equity Ratio
Equity Ratio
Debt To Asset Ratio
The company shows a very strong capacity to meet its short-term financial obligations. It holds a substantial amount of assets that can be quickly converted to cash relative to its immediate debts, providing a solid safety cushion. This indicates a low risk of near-term financial distress. A point of consideration is that its ability to generate cash directly from its core business operations is less consistent than its overall asset liquidity. While the overall position is robust, this highlights a dependency on the value and liquidity of its non-cash current assets.
| Liquidity Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Current Ratio | 3.06 | 3.36 | 4.21 | 4.08 | 3.64 |
| Quick Ratio | 2.58 | 2.91 | 3.61 | 3.49 | 3.1 |
| Cash Ratio | 0.68 | 0.45 | 1.1 | 1 | 0.59 |
| Operating Cash Flow Ratio | 0.51 | 0.15 | 0.52 | 0.5 | 0.49 |
Current Ratio
Quick Ratio
Cash Ratio
Operating Cash Flow Ratio
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Bliss GVS Pharma Ltd | 7.52 | 27.92 | Neutral | 164.00 | 9.16 | 135.00 |
Management effectiveness is assessed as weak. While the company demonstrates financial prudence with low debt levels and a strong interest coverage ratio, these strengths are significantly overshadowed by severe weaknesses across core operational and governance areas. The company suffers from highly volatile sales and profit growth, indicating a lack of stable business operations. Capital efficiency is poor, reflected in declining ROCE, weak ROE, and an exceptionally high cash conversion cycle. The most significant concern is the sharp and continuous decline in promoter and FII shareholding over the past several years, signaling a profound loss of confidence from insiders and institutional investors. This combination points to significant management challenges.
[{'Category': 'PROS', 'Metric': 'Low Financial Leverage', 'Value': '0.10 D/E Ratio', 'Assessment': 'very strong'}, {'Category': 'PROS', 'Metric': 'Interest Coverage Ratio', 'Value': '17.7x', 'Assessment': 'excellent'}, {'Category': 'CONS', 'Metric': 'Volatile Growth', 'Value': '-23% to 29% Sales Fluctuation', 'Assessment': 'inconsistent'}, {'Category': 'CONS', 'Metric': 'Capital Efficiency', 'Value': 'ROCE declined from 27% to 14%', 'Assessment': 'weak'}, {'Category': 'CONS', 'Metric': 'Promoter Holding', 'Value': 'Declined from 60% to 35%', 'Assessment': 'declining'}, {'Category': 'CONS', 'Metric': 'Cash Conversion Cycle', 'Value': '247 Days', 'Assessment': 'poor'}]
Financial Performance & Growth
The company's financial performance is characterized by extreme volatility and inconsistency. While the Trailing Twelve Months (TTM) profit growth appears strong at 55%, it follows years of significant declines, including a -59% drop in 2022. Annual sales growth has been erratic, swinging from a decline of -23.3% in 2020 to a gain of 29.5% in 2022, before slowing dramatically to 2.5% in the latest year. This unpredictability is mirrored in the profit growth. Furthermore, Operating Profit Margins (OPM) have trended downwards from historical highs of 25-29% to a more modest 16-20% range in recent years. The contribution of Other Income is also volatile and has materially impacted pre-tax profits, obscuring the performance of core operations. This pattern of unstable growth and declining profitability points to significant underlying business challenges.
| Metric (Annual %) | 2018-2020 Avg | 2021-2023 Avg | 2024 | TTM |
|---|---|---|---|---|
| Sales Growth | -3.6% | 4.6% | 2.5% | 15.0% |
| Profit Growth | 16.0% | 18.3% | 33.0% | 55.0% |
Capital Efficiency & Returns
The company's ability to generate returns from its capital is poor and has deteriorated over time. Return on Capital Employed (ROCE) has seen a substantial decline from a strong 27-31% range between 2016-2019 to a much weaker 12-14% in the last four years. This indicates capital is not being deployed productively. Similarly, the Return on Equity (ROE) is low, with the last year's figure at 12% and the 5-year average at a mere 9%. A primary driver of this poor efficiency is the extremely high Cash Conversion Cycle (CCC), which stood at 247 days in the latest year. This is a result of very high Debtor Days (192 days), signifying major issues in collecting payments from customers. Such a long cycle ties up a significant amount of capital in working capital, dragging down overall returns.
| Metric | 2018-2020 Avg | 2021-2023 Avg | 2024 |
|---|---|---|---|
| ROCE (%) | 23.7% | 12.7% | 14.0% |
| Cash Conversion Cycle (Days) | 200 | 248 | 247 |
Financial Health & Prudence
The company exhibits a mixed record in financial health. The key strength is its conservative approach to leverage. The Debt-to-Equity ratio is very low at 0.10, and total borrowings have been managed downwards. This low level of debt provides a strong financial cushion and minimizes solvency risk. This is further supported by a strong Interest Coverage Ratio of 17.7x, demonstrating that the company can comfortably meet its interest obligations. However, this prudence does not extend to its shareholder remuneration policy. The Dividend Payout ratio is low and highly inconsistent, fluctuating from 34% in 2022 to just 7% in 2023 and 2024. The inconsistency in profit sharing, despite a healthy balance sheet, is a point of weakness for shareholders seeking stable returns.
| Metric | 2018-2020 Avg | 2021-2023 Avg | 2024 |
|---|---|---|---|
| Debt to Equity Ratio | 0.14 | 0.14 | 0.10 |
| Interest Coverage (x) | 31.0x | 13.6x | 17.7x |
| Dividend Payout (%) | 10.3% | 21.0% | 7.0% |
Shareholding & Ownership Structure
The shareholding structure reveals a significant and concerning trend of declining confidence from key stakeholders. Promoter holding has been steadily diluted, falling drastically from over 60% in 2018 to just under 35% in March 2024. Such a substantial reduction in the ownership stake of the company's founders is a major red flag. This negative signal is amplified by the actions of Foreign Institutional Investors (FIIs), whose holding has also decreased from a peak of over 24% in 2020 to below 15% in 2024. The exit of both promoters and sophisticated institutional investors is a strong vote of no confidence. Consequently, the public shareholding has increased to fill the void, now standing at over 43%. This shift in ownership from strong, informed hands to a more dispersed public holding is a clear sign of weakness in investor sentiment.
| Shareholding (%) | Mar 2018 | Mar 2020 | Mar 2022 | Mar 2024 |
|---|---|---|---|---|
| Promoters | 60.16% | 41.60% | 33.14% | 34.97% |
| FIIs | 10.84% | 24.16% | 17.33% | 14.74% |
| Public | 28.86% | 31.28% | 42.87% | 43.71% |
The company's risk profile is high. The primary concerns stem from significant red flags in accounting quality and governance. The income statement is obscured by volatile 'Other Income' and 'Exceptional Items', making it difficult to assess true core profitability. Operational inefficiencies are stark, with extremely high debtor days and volatile cash flow from operations, pointing to potential issues in revenue recognition or collection. The most alarming risk is the substantial and prolonged reduction in shareholding by both promoters and Foreign Institutional Investors. This exodus of informed capital indicates a fundamental loss of confidence in the company's governance or future prospects.
Accounting & Earnings Quality
Accounting metrics raise concerns about financial transparency. The P&L is frequently distorted by volatile 'Other Income' and 'Exceptional Items' (e.g., -29 Cr in Mar 2024), obscuring core performance. The balance sheet shows extremely high Debtor Days (192 days in Mar 2024), which can signal aggressive revenue recognition or collection difficulties. Cash Flow from Operations (CFO) is also highly volatile and doesn't consistently track operating profits, with the CFO/OP ratio swinging from 143% in 2022 to 67% in 2023. These factors suggest weak financial controls and reduce the reliability of reported earnings.
Governance & Ownership Risk
The ownership trend is a major red flag. Promoter holding has been diluted from over 60% in 2017 to under 35% in 2024. Similarly, FIIs have reduced their stake from over 24% in 2020 to below 15% in 2024. A continuous and significant exit by both the company's founders and sophisticated institutional investors is a strong signal of no confidence. This exodus points toward deep-seated concerns about the company's long-term strategy, execution, or governance, representing a critical risk for remaining investors.
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10482.98Bullish
- SMA 20478.41Bullish
- SMA 50455.53Bullish
- EMA 10481.90Bullish
- EMA 20475.95Bullish
- EMA 50459.89Bullish
- DEMA 10486.19Bearish
- DEMA 20488.08Bearish
- DEMA 50482.54Bullish
- TEMA 10484.54Bullish
- TEMA 20488.51Bearish
- TEMA 50484.36Bullish
- MACD8.65Bearish
- ADX45.05Strong Trend
- IndicatorValueSignal
- RSI69.37Neutral
- CCI106.91Overbought
- ROC 90.50Bullish
- ROC 141.90Bullish
- ROC 2511.12Bullish
- Stoch K59.75Neutral
- Stoch D53.63Neutral
- IndicatorValueSignal
- BB Upper490.46Neutral
- BB Middle478.41Neutral
- BB Lower466.37Neutral
- ATR7.00Low Volatility
- IndicatorValueSignal
- MFI76.04Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 10480.75Bullish
- SMA 20464.28Bullish
- SMA 50446.35Bullish
- EMA 10478.32Bullish
- EMA 20467.81Bullish
- EMA 50442.99Bullish
- DEMA 10488.44Bearish
- DEMA 20485.49Bullish
- DEMA 50483.23Bullish
- TEMA 10487.92Bearish
- TEMA 20489.48Bearish
- TEMA 50482.95Bullish
- MACD13.51Bullish
- ADX41.55Strong Trend
- IndicatorValueSignal
- RSI75.32Overbought
- CCI88.64Neutral
- ROC 92.56Bullish
- ROC 148.97Bullish
- ROC 2511.48Bullish
- Stoch K84.34Overbought
- Stoch D83.99Overbought
- IndicatorValueSignal
- BB Upper501.59Neutral
- BB Middle464.28Neutral
- BB Lower426.96Neutral
- ATR9.24Low Volatility
- IndicatorValueSignal
- MFI94.64Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 10465.66Bullish
- SMA 20447.75Bullish
- SMA 50395.47Bullish
- EMA 10468.59Bullish
- EMA 20451.87Bullish
- EMA 50404.63Bullish
- DEMA 10485.16Bullish
- DEMA 20483.03Bullish
- DEMA 50473.21Bullish
- TEMA 10488.28Bearish
- TEMA 20482.08Bullish
- TEMA 50N/AN/A
- MACD23.08Bullish
- ADX48.05Strong Trend
- IndicatorValueSignal
- RSI78.73Overbought
- CCI132.37Overbought
- ROC 910.29Bullish
- ROC 1414.77Bullish
- ROC 259.83Bullish
- Stoch K87.97Overbought
- Stoch D91.83Overbought
- IndicatorValueSignal
- BB Upper492.71Neutral
- BB Middle447.75Neutral
- BB Lower402.79Neutral
- ATR14.37Low Volatility
- IndicatorValueSignal
- MFI90.66Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
- IndicatorValueSignal
- SMA 10447.58Bullish
- SMA 20423.40Bullish
- SMA 50331.50Bullish
- SMA 100269.01Bullish
- SMA 200213.59Bullish
- EMA 10452.90Bullish
- EMA 20420.14Bullish
- EMA 50351.72Bullish
- EMA 100293.80Bullish
- EMA 200240.87Bullish
- DEMA 10482.99Bullish
- DEMA 20478.63Bullish
- DEMA 50433.10Bullish
- DEMA 100374.78Bullish
- DEMA 200310.46Bullish
- TEMA 10482.67Bullish
- TEMA 20488.98Bearish
- TEMA 50468.94Bullish
- TEMA 100420.43Bullish
- TEMA 200354.82Bullish
- MACD43.44Bullish
- ADX60.46Strong Trend
- IndicatorValueSignal
- RSI79.41Overbought
- CCI130.35Overbought
- ROC 1420.83Bullish
- ROC 2568.04Bullish
- Stoch K95.43Overbought
- Stoch D92.95Overbought
- IndicatorValueSignal
- BB Upper515.70Neutral
- BB Middle423.40Neutral
- BB Lower331.10Neutral
- ATR21.31Low Volatility
- IndicatorValueSignal
- MFI74.89Neutral
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 20264.61Bullish
- SMA 50201.47Bullish
- EMA 20286.02Bullish
- EMA 50222.62Bullish
- DEMA 20357.56Bullish
- DEMA 50283.26Bullish
- TEMA 20395.41Bullish
- TEMA 50320.71Bullish
- MACD58.51Bullish
- ADX51.42Strong Trend
- IndicatorValueSignal
- RSI83.29Overbought
- CCI306.14Overbought
- ROC 14104.71Bullish
- ROC 25153.24Bullish
- Stoch K92.17Overbought
- Stoch D92.94Overbought
- IndicatorValueSignal
- BB Upper420.97Overbought
- BB Middle264.61Neutral
- BB Lower108.25Neutral
- ATR35.23High Volatility
- IndicatorValueSignal
- MFI87.09Overbought
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bearish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Strong Bearish
- IndicatorValueSignal
- SMA 6244.97Bullish
- SMA 12202.92Bullish
- SMA 24166.96Bullish
- EMA 6274.12Bullish
- EMA 12224.40Bullish
- EMA 24183.72Bullish
- DEMA 6339.92Bullish
- DEMA 12283.65Bullish
- DEMA 24234.10Bullish
- TEMA 6374.20Bullish
- TEMA 12318.67Bullish
- TEMA 24267.97Bullish
- MACD37.26Bullish
- ADX28.79Strong Trend
- IndicatorValueSignal
- RSI76.39Overbought
- CCI437.91Overbought
- ROC 25244.09Bullish
- ROC 50451.62Bullish
- Stoch K72.92Neutral
- Stoch D65.32Neutral
- IndicatorValueSignal
- BB Upper312.14Overbought
- BB Middle176.34Neutral
- BB Lower40.54Neutral
- ATR47.58High Volatility
- IndicatorValueSignal
- MFI90.14Overbought